Genetic testing for age-related macular degeneration: not indicated now.
Level V
Where this comes from
- Record sourced from PubMed, PMID 25789813.
- Also identified by DOI 10.1001/jamaophthalmol.2015.0369.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Age-related macular degeneration is a very common condition that is caused by a complex interplay of genetic and environmental factors. It is likely that, in the future, genetic testing will allow physicians to achieve better clinical outcomes by administering specific treatments to patients based on their genotypes. However, improved outcomes for genotyped patients have not yet been demonstrated in a prospective clinical trial, and as a result, the costs and risks of routine genetic testing currently outweigh the benefits for patients with age-related macular degeneration.
Medical subject headings
- Genetic Predisposition to Disease
- Genetic Testing
- Macular Degeneration